Sydänkeskus TO2

Julkaisut 2014
Publications 2014

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Airaksinen J. Uutta akuutin eteisvärinän kardioversiosta.
2 Airaksinen J. Lääkärin käsikirja.
3 Airaksinen J et al. Percutaneous Coronary Intervention in the Patient on Oral Anticoagulation.
4 Anttalainen U, Kalleinen N. Uniapnea ja sydän- ja verisuonisairaudet.
5 Autio A et al. Assessment of blood flow with (68)Ga-DOTA PET in experimental inflammation: a validation study using (15)O-water.
6 Badeau RM et al. Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPARgamma agonist.
7 Beer AJ et al. PET/CT imaging of integrin avß3 expression in human carotid atherosclerosis.
8 Biancari F et al. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged 50 years (the Coronary aRtery diseAse in younG adultS Study).
9 Biancari F et al. Treatment of esophageal perforation in octogenarians: a multicenter study.
10 Biancari F et al. Meta-analysis on the performance of the EuroSCORE II and the Society of Thoracic Surgeons Scores in patients undergoing aortic valve replacement.
11 Biancari F et al. The effect of prior percutaneous coronary intervention on the immediate and late outcome after coronary artery bypass grafting: systematic review and meta-analysis.
12 Biancari F et al. Basic data from 176 studies on the immediate outcome after aortic valve replacement with or without coronary artery bypass surgery.
13 Biancari F et al. Determinants of outcome after isolated coronary artery bypass grafting in patients aged ?50 years (from the Coronary aRtery diseAse in younG adultS study).
14 Biancari F et al. Outcome of patients with esophageal perforations: A multicenter study.
15 Blomster JI et al. The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
16 Danad I et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging.
17 Edvardsen T et al. The year 2013 in the European Heart Journal--Cardiovascular Imaging. Part I.
18 Eerola K. Alpha- and Gamma-Melanocyte Stimulating Hormones In Obesity. A study of the key central areas of metabolic regulation.
19 Eerola K et al. Alpha-MSH overexpression in the nucleus tractus solitarius decreases fat mass and elevates heart rate.
20 Gunn J. Periprocedural Prognostic Factors In Coronary Interventions - Retrospective Studies.
21 Gunn J et al. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation.
22 Gunn JM et al. The prognostic significance of declining health-related quality of life scores at 6 months after coronary artery bypass surgery.
23 Gunn JM et al. Thirty-year results after implantation of the Björk-Shiley Convexo-Concave Heart valve prosthesis.
24 Heinonen I et al. Circulating N-terminal brain natriuretic peptide and cardiac function in response to acute systemic hypoxia in healthy humans.
25 Heinonen I et al. Reply to "Letter to the editor: 'Deconstructing the dogma of sympathetic restraint and its role in the cardiovascular response to exercise'".
26 Hietala P et al. Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture.
27 Huovinen V et al. Vertebral bone marrow glucose uptake is inversely associated with bone marrow fat in diabetic and healthy pigs: [(18)F]FDG-PET and MRI study.
28 Inkinen J et al. Penetrating trauma; experience from southwest Finland between 1997 and 2011, a retrospective descriptive study.
29 Joutsiniemi E et al. Absolute flow or myocardial flow reserve for the detection of significant coronary artery disease?
30 Karjalainen P et al. Optimal stent design: past, present and future.
31 Kinnunen E et al. Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery.
32 Kiugel M et al. Dimeric [(68)Ga]DOTA-RGD peptide targeting ?v? 3 integrin reveals extracellular matrix alterations after myocardial infarction.
33 Kivelä R et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.
34 Kiviniemi T et al. Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy.
35 Kiviniemi T et al. Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention.
36 Kiviniemi T et al. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.
37 Knuuti J, Järvinen J. CardioPulse. Radiation exposure and the risk of cancer for interventional cardiologists and electrophysiologists.
38 Knuuti J, Saraste A. Combined anatomical and functional CT imaging for the detection of coronary artery disease.
39 Kristensen SD et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement. The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).
40 Kytö V et al. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis.
41 Kytö V et al. Rate and patient features associated with recurrence of acute myocarditis.
42 Kytö V et al. Likelihood and predictors of ST-elevation in patients hospitalized for myocardial infarction.
43 Kytö V et al. Association of age and gender with anterior localization of STEMI.
44 Kytö V et al. Gender, age and risk of ST segment elevation myocardial infarction.
45 Kytö V et al. Association of age and gender with risk for non-ST-elevation myocardial infarction.
46 Kytö V et al. Chronic constrictive pericarditis in general adult population.
47 Lahtela H. Percutaneous Coronary Intervention in Patients with Atrial Fibrillation:A Study of Factors Affecting Outcome, with a Special Emphasis on Periprocedural Antithrombotic Treatment.
48 Lautamäki A et al. Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study.
49 Lautamäki R et al. Recent developments in imaging of myocardial angiotensin receptors.
50 Lund J et al. Paint it black: and seal with a disk.
51 Mähönen M et al. Sepelvaltimotaudin kajoavia toimenpiteitä koskevien rekisteritietojen luotettavuus ja kehityssuunnat 1994-2011.
52 Nammas W et al. Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.
53 Nuotio I et al. Time to cardioversion for acute atrial fibrillation and thromboembolic complications.
54 Palomäki A. Eteisvärinäpotilaiden aivohalvaukset ja kallonsisäiset verenvuodot.
55 Plein S et al. The year 2013 in the European Heart Journal--Cardiovascular Imaging: Part II.
56 Puurunen M et al. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
57 Puurunen MK et al. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
58 Rinne P et al. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
59 Rubboli A et al. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
60 Rubboli A et al. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry.
61 Salomaa V et al. Sepelvaltimotautitapahtumien ilmaantuvuus on vähentynyt ja ennuste parantunut FINAMI-tutkimuksen tuloksia 1993-2007.
62 Salomäki SP et al. Visualization of pericarditis by fluorodeoxyglucose PET.
63 Saraste A, Knuuti J. Prognosis of non-obstructive coronary plaques with high-risk CT morphology.
64 Saraste A et al. Milloin eteiskorvake tai avoin soikea aukko kannattaa sulkea katetrilla?
65 Savontaus M. Eteisvärinäpotilaan tukos- ja vuotoriskin arviointi.
66 Savukoski T et al. Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies.
67 Sipilä J et al. The quality of internal medicine hospital care during summer holiday season.
68 Toffol E et al. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life.
69 Toffol E et al. The relationship between mood and sleep in different female reproductive states.
70 Toffol E et al. The effect of hormone therapy on serum melatonin concentrations in premenopausal and postmenopausal women: A randomized, double-blind, placebo-controlled study.
71 Tuomainen PO et al. Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.
72 Uotila S et al. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
73 Utriainen KT et al. Sleep apnoea is associated with major cardiac events in peripheral arterial disease.
74 Varho V et al. Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.
75 Vepsäläinen T et al. Prolonged P wave duration predicts stroke mortality among type 2 diabetic patients with prevalent non-major macrovascular disease.
76 Virtanen R et al. Self-detection of atrial fibrillation in an aged population: the LietoAF Study.
77 Virtanen S et al. White matter damage of the brain is associated with poor outcome in vascular surgery patients with claudication: A pilot study.
Julkaisutietokanta 6.10.2015 Publications Data Base 6.10.2015